Clustering in $^{18}$O -- absolute determination of branching ratios via high-resolution particle spectroscopy

Autor: Pirrie, S., Wheldon, C., Kokalova, Tz., Bishop, J., Hertenberger, R., Wirth, H. -F., Bailey, S., Curtis, N., Dell'Aquila, D., Faestermann, Th., Mengoni, D., Smith, R., Torresi, D., Turner, A.

The determination of absolute branching ratios for high-energy states in light nuclei is an important and useful tool for probing the underlying nuclear structure of individual resonances: for example, in establishing the tendency of an excited state

Externí odkaz: http://arxiv.org/abs/1912.00300

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Autor: Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Patel A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Barnes E; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Willicombe M; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Siebert S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., de Silva TI; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Bowden SJ; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Billingham L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Richter A; Clinical Immunology Service, University of Birmingham, Edgbaston, Birmingham, UK., Carroll M; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Carr EJ; The Francis Crick Institute, London, UK., Beale R; The Francis Crick Institute, London, UK., Rea D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Parry H; Department of Haematology, University Hospitals Birmingham NHS Foundations Trust, Birmingham, UK., Pirrie S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Lim Z; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Satsangi J; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dunachie SJ; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cook G; National Institute for Health Research Leeds MIC, University of Leeds, Leeds, UK., Miller P; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK., Basu N; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Gilmour A; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Hodgkins AM; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Evans L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Hughes A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., Longet S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Centre International de Recherche en Infectiologie, Team GIMAP (Saint-Etienne), Université Claude Bernard Lyon 1, Inserm, CNRS, Lyon, France., Meacham G; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Yong KL; Cancer Institute, Department of Haematology, University College London, London, UK., A'Hearne MJ; Department of Haematology, Leicester Royal Infirmary, Leicester, UK., Koh MBC; Infection and Immunity Clinical Academic Group, St George's, University of London and Department of Haematology, St George's Hospital NHS Foundation Trust, London, UK., Burns SO; Clinical Immunology, Royal Free Hospital, Hampstead, London, UK; Institute of Immunity and Transplantation, University College London, Hampstead, London, UK., Orchard K; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Paterson C; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., McIlroy G; Department of Haematology, University Hospitals Birmingham NHS Foundations Trust, Birmingham, UK., Murray SM; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thomson T; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Dimitriadis S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Goulston L; National Institute of Health Research, Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Miller S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Keillor V; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Prendecki M; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Thomas D; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Kirkham A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK., McInnes IB; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Kearns P; Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, UK; National Institute for Health Research, Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Electronic address: p.r.kearns@bham.ac.uk.

Publikováno v: The Lancet. Rheumatology [Lancet Rheumatol] 2024 Jun; Vol. 6 (6), pp. e339-e351. Date of Electronic Publication: 2024 May 08.

Precision branching-ratio measurements in 18O.

Autor: Pirrie, S.¹ (AUTHOR) s.pirrie@pgr.bham.ac.uk, Wheldon, C.¹ (AUTHOR), Kokalova, Tz.¹ (AUTHOR), Bishop, J.^1,2 (AUTHOR), Faestermann, Th.³ (AUTHOR), Hertenberger, R.⁴ (AUTHOR), Wirth, H. F.⁴ (AUTHOR), Bailey, S.¹ (AUTHOR), Curtis, N.¹ (AUTHOR), Dell'Aquila, D.^5,6 (AUTHOR), Mengoni, D.⁷ (AUTHOR), Smith, R.^1,8 (AUTHOR), Torresi, D.^1,9 (AUTHOR), Turner, A.¹ (AUTHOR)

Publikováno v: European Physical Journal A -- Hadrons & Nuclei. Apr2021, Vol. 57 Issue 4, p1-12. 12p.

Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study.

Autor: Wheelwright S; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RX, UK. s.wheelwright@sussex.ac.uk., Matthews L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RX, UK., Jenkins V; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RX, UK., May S; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RX, UK., Rea D; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Fairbrother P; Independent Cancer Patients' Voice, London, UK., Gaunt C; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Young J; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Pirrie S; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Wallis MG; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK., Fallowfield L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RX, UK.

Publikováno v: Trials [Trials] 2023 Oct 14; Vol. 24 (1), pp. 670. Date of Electronic Publication: 2023 Oct 14.

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.

Autor: Barnes E; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Goodyear CS; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Willicombe M; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Gaskell C; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Siebert S; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., I de Silva T; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK., Murray SM; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Rea D; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Carroll M; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Pirrie S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Bowden SJ; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Dunachie SJ; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Richter A; Clinical Immunology Service, University of Birmingham, Edgbaston, Birmingham, UK., Lim Z; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Satsangi J; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cook G; National Institute for Health Research, Leeds MIC, University of Leeds, Leeds, UK., Pope A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Hughes A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Harrison M; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., Lim SH; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Miller P; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK., Klenerman P; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Basu N; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Gilmour A; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK., Irwin S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Meacham G; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Marjot T; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dimitriadis S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kelleher P; Department of Infectious Diseases, Imperial College London, School of Medicine Chelsea and Westminster Hospital, London, UK., Prendecki M; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Clarke C; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Mortimer P; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., McIntyre S; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Selby R; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Meardon N; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK., Nguyen D; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Tipton T; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Longet S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Laidlaw S; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Orchard K; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Ireland G; UK Health Security Agency (UKHSA), Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Thomas D; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UK., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK.; National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Kirkham A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Edgbaston, Birmingham, UK., McInnes IB; College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK. Iain.McInnes@glasgow.ac.uk.

Publikováno v: Nature medicine [Nat Med] 2023 Jul; Vol. 29 (7), pp. 1760-1774. Date of Electronic Publication: 2023 Jul 06.